Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual’s risk of developing pancreatic cancer by 62 percent, according to new research.
Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual’s risk of developing pancreatic cancer by 62 percent, according to new research.